Log in to save to my catalogue

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8775991

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

About this item

Full title

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2022-01, Vol.23 (2), p.786

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis of MetS encompasses multiple genetic and acquired entities that fall under the umbrella of insulin resistance and chronic low-grade inflammation. If left untreated, MetS is...

Alternative Titles

Full title

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8775991

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8775991

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms23020786

How to access this item